Carrie L. Nieman, MD

Jennifer D Yeagle, M.Ed., CCC-A earned her Master’s degree in Audiology from University of Virginia in 1998. She completed her bachelor’s degree in Communication Disorders/Speech Language Pathology from the University of Central Florida in 1995. She joined the Johns Hopkins Listening Center in 1999 and specializes in cochlear implantation assessment, programming and case management for adults with special interest in the elderly population.

Christie Adams is a neurosurgical physician assistant who specializes in brain tumors and trigeminal neuralgia. She cares for adult patients with these conditions both before and after surgery. After she obtained her undergraduate degree at Carnegie Mellon University, Adams completed a master’s degree in biological sciences at University of Maryland Baltimore County. This was followed by a second master’s degree in physician assistant studies from Thomas Jefferson University in Philadelphia, Pennsylvania

Neurologist Kelly Mills cares for patients who have movement disorders such as ataxia, dystonia, Parkinson’s disease, atypical parkinsonism and tremor. He evaluates and manages patients needing advanced therapies, such as deep brain stimulation, focused ultrasound or medication infusions to manage their movement symptoms. Additionally, he provides botulinum toxin treatment for various disorders. Dr. Mills earned his medical degree from the University of Maryland School of Medicine. He completed residency training in neurology at the University of California, San Francisco School of Medicine and remained there for fellowship training in movement disorders, which had a particular emphasis on deep brain stimulation to treat Parkinson’s disease, tremor and dystonia. Dr. Mills also holds a Master of Health Sciences from the Johns Hopkins Bloomberg School of Public Health. In his research, Dr. Mills explores the cognitive dysfunction that can occur in movement disorders such as Parkinson’s disease. He is particularly interested in describing the role of the basal ganglia in cognition, especially in the context of various diseases that can affect this structure. His work focuses on clarifying how certain treatments might affect cognitive and psychiatric problems. He also works to develop new imaging biomarkers to detect mechanisms of disease, such as neuroinflammation in Parkinson’s disease.